• 1
    Garcia-Tsao G, Lee FY, Barden GE, Cartun R, West AB. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 1995;108:18351841.
  • 2
    Wiest R, Das S, Cadelina G, Garcia-Tsao G, Milstien S, Groszmann RJ. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J Clin Invest 1999;104:12231233.
  • 3
    Perez-Paramo M, Muñoz J, Albillos A, Portero F, Freire I, Santos M, Berrocal J. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology 2000;1:4348.
  • 4
    Cirera I, Bauer TM, Navasa M, Vila J, Grande L, Taurá P, Fuster J, et al. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol 2001;34:3237.
  • 5
    Meyer J, Traber LD, Nelson S, Lentz CW, Nakazawa H, Herndon DN, Noda H, et al. Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis. J Appl Physiol 1992;73:324328.
  • 6
    Le Moine O, Soupison T, Sogni P, Marchant A, Moreau R, Hadengue A, Goldman M, et al. Plasma endotoxin and tumor necrosis factor-α in the hyperkinetic state of cirrhosis. J Hepatol 1995;23:391395.
  • 7
    Chin-Dustin JP, Rasaratnam B, Jenninngs GJ, Dudley FJ. Effect of fluoroquinolone on the enhanced nitric oxide–induced peripheral vasodilation seen in cirrhosis. Ann Intern Med 1997;127:985988.
  • 8
    Anker SD, Egerer K, Volk HD, Kox WJ, Poole-Wilson PA, Coats AJS. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 1997;79:14261430.
  • 9
    Lequier LL, Nikaidoh H, Leonard SR, Bokovoy JL, White ML, Scannon PJ, Giroir BP. Preoperative and postoperative endotoxemia in children with congenital heart disease. Chest 2000;117:17061712.
  • 10
    Schumann RR, Latz E. Lipopolysaccharide-binding protein. Chem Immunol 2000;74:4260.
  • 11
    Opal SM, Scannon PJ, Vincent JL, White M, Carroll SF, Palardy JE, Parejo NA, et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis 1999;180:15841589.
  • 12
    Ziegler-Heitbrock JP, Ulevitch RJ. CD14: cell surface receptor and differentiation marker. Immunol Today 1993;14:121125.
  • 13
    Gardin JM, Tobis JM, Dabestani A, Smith C, Elkayam U, Castleman E, White D, et al. Superiority of two-dimensional measurement of aortic vessel diameter in Doppler echocardiographic estimates of left ventricular stroke volume. J Am Coll Cardiol 1985;6:6674.
  • 14
    Albillos A, Rossi I, Cacho G, Martínez MV, Millán I, Abreu L, Barrios C, et al. Enhanced endothelium-dependent vasodilation in patients with cirrhosis. Am J Physiol 1995;28:G459464.
  • 15
    Albillos A, Lledo JL, Rossi I, Perez-Paramo M, Tabuenca MJ, Bañares R, Iborra J, et al. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function. Gastroenterology 1995;109:12571265.
  • 16
    Fukui H, Brauner B, Bode JC, Bode CH. Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 1991;12:162169.
  • 17
    Guarner C, Soriano G, Tomás A, Bulbena O, Novella MT, Balanzo J, Vilardell F, et al. Increased serum nitrates and nitrate levels in patients with cirrhosis: relationship to endotoxinemia. Hepatology 1993;18:11391143.
  • 18
    Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Lu RH, Hsu WC, et al. Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 1995;22:165172.
  • 19
    Von Baehr V, Döcke WD, Plauth M, Liebenthal C, Küpferling S, Lochs H, Baumgarten R, et al. Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumor necrosis factor receptors as well as effector cell desensitization. Gut 2000;47:281287.
  • 20
    Hanck C, Rossol S, Bocker U, Tokus M, Singer MV. Presence of plasma endotoxin is correlated with tumour necrosis factor receptor levels and disease activity in alcoholic cirrhosis. Alcohol Alcohol 1998;33:606608.
  • 21
    Tilg H, Diehl AM. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000;343:14671476.
  • 22
    Van Deventer SJ, Buller HR, Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 1990;76:25201526.
  • 23
    Le Roy D, Di Padova F, Adachi Y, Glauser MP, Calandra T, Heumann D. Critical role of lipopolysaccharide-binding protein and CD14 in immune responses against gram-negative bacteria. J Immunol 2001;167:27592765.
  • 24
    Niebauer J, Volk HD, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson P, et al. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 1999;353:18381842.
  • 25
    Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis: a role for nitric oxide? Lancet 1991;337:776778.
  • 26
    Gross SS, Jaffe EA, Levi R, Kilbourn RG. Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages. Biochem Biophys Res Commun 1991;178:823839.
  • 27
    Rosenkranz-Weiss P, Sessa WC, Milstien S, Kaufman S, Watson CA, Pober JS. Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. J Clin Invest 1994;93:22362243.
  • 28
    Castor G, Klocke RK, Stoll M, Helms J, Niedermark I. Simultaneous measurement of cardiac output by thermodilution, thoracic electrical bioimpedance and Doppler ultrasound. Br J Anesthesia 1994;72:133138.
  • 29
    Ferro D, Quintarelli C, Lattuada A, Leo R, Alessandrini M, Mannucci PM, Violi F. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia. Hepatology 1996;23:13771383.
  • 30
    Llovet JM, Bartoli R, Planas R, Vinado B, Pérez J, Cabré E, Arnal J, et al. Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to hemorrhagic shock. Hepatology 1996;23:781787.
  • 31
    Guarner C, Runyon BA, Heck M, Young S, Sheiki MY. Effect of longterm trimetropim-sulfamethoxazole prophylaxis on ascites formation, bacterial translocation, spontaneous bacterial peritonitis and survival in cirrhotic rats. Dig Dis Sci 1999;44:19571962.
  • 32
    Madrid AM, Hurtado C, Venegas M, Cumsille F, Defilippi C. Long-term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth and liver function. Am J Gastroenterol 2001;96:12511255.
    Direct Link:
  • 33
    Andus T, Bauer J, Gerok W. Effects of cytokines on the liver. Hepatology 1991;13:364375.
  • 34
    Campillo B, Chabrier PE, Pelle G, Sediame S, Atlan G, Fouet P, Adnot S. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis. Hepatology 1995;22:14231429.
  • 35
    Pannen BH, Bauer M, Zhang JX, Robotham JL, Clemens MG. Endotoxin pretreatment enhances portal venous contractile response to endothelin-1. Am J Physiol 1996;270:H715.